Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: January 27, 2023

Authorized Generic Drugs

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

FDA Authorized Generic Drugs

Tradename Generic Name Company NDA Dosageform Marketing Start
ELIDEL pimecrolimus Oceanside Pharmaceuticals 021302 CREAM Nov 26, 2018
ATACAND candesartan cilexetil American Health Packaging 020838 TABLET Sep 12, 2016
ALPHAGAN P brimonidine tartrate Pacific Pharma, Inc. 021262 SOLUTION/ DROPS Feb 28, 2022
BUMEX bumetanide American Health Packaging 018225 TABLET Mar 20, 2020
INDERAL LA propranolol hydrochloride Direct Rx 018553 CAPSULE, EXTENDED RELEASE Oct 27, 2017
PRED FORTE prednisolone acetate Pacific Pharma, Inc. 017011 SUSPENSION/ DROPS Aug 19, 1997
>Tradename >Generic Name >Company >NDA >Dosageform >Marketing Start

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.